Our scans show where there is patchy ventilation in patients with lung disease, and show us which parts of the lung improve ...

A study led by Aston University's Dr. Gemma Heath and Dr. Prasad Nagakumar from Birmingham Children's Hospital has shown that ...

Outcome measures Children/carers attending hospital were asked how they identify an empty salbutamol inhaler; dose counters in the preventer inhalers and disposal practices were reviewed. Results 157 ...

A.H. Morice, Castle Hill Hospital, Hull, England; J.R. Stradling, Churchill Hospital, Oxford, England; N.C. Barnes London Chest Hospital, London, England; the COMPACT ...

A study led by Aston University’s Dr Gemma Heath and  Dr Prasad Nagakumar from Birmingham Children’s Hospital, has shown that treatment and diagnosis for preschool wheeze needs more effective evidence ...

A study led by Aston University's Dr Gemma Heath and Dr Prasad Nagakumar from Birmingham Children's Hospital, has shown that treatment and diagnosis for preschool wheeze needs more effective ...

A study led by Aston University's Dr Gemma Heath and Dr Prasad Nagakumar from Birmingham Children's Hospital, has shown that treatment and diagnosis ...

The new scanning technique allows the team to quantify the degree of improvement in ventilation when patients have a treatment, in this case, a widely used inhaler, the bronchodilator, salbutamol.

GSK has developed a new propellant technology for inhaler devices that drastically ... phase 3 testing in GSK’s asthma product Ventolin (salbutamol) next year, and according to the drugmaker ...

The new scanning technique allows the team to quantify the degree of improvement in ventilation when patients have a treatment, in this case a widely used inhaler, the bronchodilator, salbutamol.

The new scanning technique allows the team to quantify the degree of improvement in ventilation when patients undergo treatment, in this case a widely used inhaler, the bronchodilator, salbutamol.

The companys name was changed from Glindia Ltd to Glaxo India Ltd. In the year 1990, the production of the bulk drug, cephalexin was commenced at Ankleshwar and the salbutamol inhalers at Nashik.